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A s people are living longer, the disease burden is shifting toward diseases of old age, including an increasing prevalence of dementia, most commonly because of Alzheimer disease (AD). The risk of developing dementia doubles every 5 years after the age of 65 years. 1 There are currently 5.1 million Americans aged >65 years living with dementia, and this number is expected to reach 13.8 million by the year 2050. 2 Despite an increasing prevalence of dementia, the FHS (Framingham Heart Study) recently showed that the agespecific incidence of dementia has steadily declined over the previous 3 decades (Figure) . 3 In other words, whereas the overall number of people affected by dementia will continue to increase because of population aging, an individual's risk of developing dementia by a specific age has decreased by as much as 20% each decade over the past 30 years. Other studies have also pointed toward a declining incidence of dementia in the United States and Europe. [4] [5] [6] The Health and Retirement Study also reported a decline in dementia prevalence in the United States from the year 2000 to 2012. 7 Collectively, these studies provide hope that some cases of dementia can be prevented or delayed.
The factors underlying changing temporal trends in dementia are not entirely clear. It is important to understand what underlies the reduction in dementia incidence so that we can promote those factors most likely to reduce dementia incidence even further. This is crucial because, to date, we have no drugs that can permanently halt or reverse clinical dementia. Uncovering modifiable risk factors that can be targeted for the primary prevention of dementia may represent the most feasible approach to managing the growing dementia epidemic.
This review examines whether better cardiovascular health, including better management of stroke risk factors, could be responsible for the observed declining incidence of dementia. We draw on evidence from the FHS and other communitybased prospective cohort studies.
Vascular Contributions to Dementia
The brain pulses with each heartbeat. Each thought requires the complex coordination of neuronal firing coupled with local increases in blood flow. The brain does not store energy and is dependent on constant blood flow to meet metabolic demands and to remove metabolic waste such as amyloid beta (Aβ) oligomers. Sudden gross disruption to brain blood flow has obvious and deleterious consequences for the brain, as in the case of stroke and anoxic brain injury. However, vascular brain disease can accumulate silently, and this is far more common than overt stroke. This has been confirmed by the widespread use of structural brain imaging, which has identified markers of small-vessel disease, such as lacunar infarcts, white matter hyperintensities, and more recently enlarged perivascular spaces, microinfarcts, and cerebral microbleeds in the brains of many elderly adults who present without overt neurological symptoms or signs of a stroke. However, the silent (covert) accumulation of cerebrovascular disease may not be benign. Covert cerebrovascular disease seems to increase the risk of dementia, 8 and autopsy studies identify the co-occurrence of vascular and AD-type pathology. 9 Historically, dementia caused by cerebrovascular disease and AD were considered mutually exclusive and diagnostic criteria (DSM-IIIR [Diagnostic and Statistical Manual III Revised]) forbade a diagnosis of probable AD when cognitive deficits were likely because of cerebrovascular disease. Diagnostic criteria have since changed on the weight of evidence linking cerebrovascular disease and AD. In 2002, an influential review by de la Torre 10 challenged the current dogma by highlighting the links between vascular risk factors and AD. More recently, the American Heart Association and American Stroke Association released a scientific statement on vascular cognitive impairment outlining the importance of vascular contributions to cognitive impairment and dementia. 11 Acknowledgment that vascular risk factors contribute to the cause of dementia provokes a tantalizing question: Can improvement in cardiovascular health reduce the risk of developing dementia? In the following section, we examine evidence linking specific vascular risk factors to dementia occurrence. We discuss temporal trends in such risk factors to scrutinize whether improvements in vascular health can explain the declining incidence of dementia.
Vascular Risk Factors: Associations With Dementia and Trends Over Time Stroke and Dementia
A series of strokes leading to dementia was once referred to as multi-infarct dementia, characterized by a stepwise decline in cognitive function. 12 Nowadays, multi-infarct dementia is considered as just 1 cause of vascular dementia (VaD) and stroke is a recognized risk factor for AD and VaD. A systematic review and meta-analysis of 14 730 adults, including 862 with a history of stroke and 13 868 controls, demonstrated that a history of stroke increased the risk of AD dementia by 59%. 13 The presence of vascular risk factors attenuated, but failed to explain completely, the association between stroke and AD. Stroke can cause a cascade of inflammatory processes and alter the permeability of the blood-brain barrier, exposing the brain to toxins originating in the systemic circulation. 13 A clinical stroke may also only reflect the tip of the iceberg in the sense that patients with stroke may harbor widespread small-vessel disease, which may compromise cerebral hemodynamics beyond the site of the clinical lesion. In the presence of AD pathology, a stroke may also serve as a catalyst for the onset of clinically symptomatic dementia. In summary, a history of stroke is a risk factor for dementia.
Trends in Stroke Risk
Cohort studies have reported a declining stroke incidence in both the United States and Europe. The FHS reported a decrease in the age-adjusted incidence of stroke between 1950 and 2004. 14 The Rotterdam study reported a reduced risk of stroke between 1990 and 2008 in men only, 15 whereas the Atherosclerosis Risk in the Communities study reported a reduced risk of stroke incidence between 1987 and 2011, but only in those aged ≥65 years. 16 Thus, the incidence of stroke seems to be declining, with some differences reported by age and sex.
Hypertension and Dementia
Hypertension is a major risk factor for stroke and cerebrovascular disease, which in turn increases the risk of dementia. In addition to increasing the risk of hemorrhage, sustained exposure to high-pressure flow can alter the brains autoregulatory thresholds and cause remodeling of small cerebral vessels leading to ischemic injury. 17 Associations between hypertension and cognitive impairment are modified by the age at which blood pressure (BP) is measured, with midlife hypertension being associated with later-life cognitive decline across numerous studies. 18 Hypertension also seems to increase the risk of incident VaD, 19 yet its relationship with incident AD remains unclear. 20 The evidence is also lacking as to whether treating hypertension can lower the risk of developing incident dementia 21 although the Systolic-Hypertension in Europe study reported that BP-lowering therapy reduced the risk of dementia by 55%. 22 Results from the SPRINT-MIND (Systolic BP Intervention Trial: Memory and Cognition in Decreased Hypertension), which are anticipated in 2017, may add clarity to this issue. A recent American Heart Association position statement concluded that although substantial evidence links hypertension to the development of cognitive impairment, it remains unclear whether BP-lowering treatment prevents or reverses cognitive decline. 23 
Trends in Hypertension and Its Treatment
In the FHS, BP levels have fallen since the 1970s. 24 In the NHANES study (National Health and Nutrition Examination Survey), the prevalence of hypertension fell between 1960 and 1991, before increasing between 1999 and 2000. 25 In Europe, the Rotterdam study reported an increase in the rates of hypertension between 1990 and 2000. Treatment for hypertension did not increase over time in the Rotterdam study, except in the oldest men. 15 In contrast, changes in the treatment of BP seem to have been more aggressive in the United States, with both the FHS and Cardiovascular Health Study reporting increases over time in the number of participants treated for high BP. 24, 26 Thus, treatment of hypertension has increased in the United States as has BP control in hypertension.
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Smoking and Dementia
Smoking is a major risk factor for cardiovascular disease, including stroke, 28 as well as all-cause dementia, AD, and cognitive decline. 29 Meta-analysis suggests that current smokers, relative to never smokers and former smokers, have a 79% and 70% increased risk of AD, respectively. 29 Mechanisms linking smoking to dementia may include concomitant vascular disease, chronic low-grade inflammation, and oxidative stress.
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Trends in Smoking
Census data suggest that rates of smoking have steadily decreased in the United States for more than half a century. 30 On a global scale, the estimated prevalence of daily smoking has decreased since 1980 although the total number of smokers has increased owing to population growth and improved survival among smokers. 31 For patients aged 50 years in the FHS, the prevalence of cigarette smoking has decreased from 44% to 19% among those without diabetes mellitus and from 58% to 17% among those with diabetes mellitus. 24 In Europe, analysis of 9 countries suggests greater reductions in the rates of smoking between 1985 and 2000 in people who were highly educated. 32 Thus, overall, there have been large reductions in the global rates of smoking.
Lipids and Dementia
Cholesterol regulates the production and clearance of brain Aβ. 33 The APOE gene is the strongest genetic risk factor for sporadic AD and is involved in cholesterol transport. In the FHS, suboptimal high-density lipoprotein cholesterol levels (≤40 mg/dL) and a high total cholesterol (TC)/high-density lipoprotein cholesterol ratio (≥5) are associated with incident stroke, whereas low-density lipoprotein cholesterol levels are not. 34 However, in the FHS, we did not find an association between plasma TC and the risk of AD dementia. 35 In contrast, a 2008 review of 18 prospective studies suggested that high TC in midlife but not later-life may be associated with an increased risk of all-cause dementia and AD. 36 The reviewed studies did not report any significant associations between TC and the risk of VaD. Despite some observational studies suggesting that statin use may protect against the risk of dementia, 37 a 2016 Cochrane review of randomized controlled trials concluded that the use of statins in later-life to individuals at risk of vascular disease did not prevent dementia. 38 In summary, high midlife TC may be associated with an increased risk of dementia although the current evidence does not suggest that cholesterol-lowering therapy reduces the risk of dementia.
Trends in TC and High-Density Lipoprotein Cholesterol
In the FHS, we have observed a decrease in TC levels and increases in high-density lipoprotein levels over time. 3, 24, 39 The NHANES study reported decreases in TC from 1960 to 2002, 40 whereas neither the NHANES nor Rotterdam studies found changes in high-density lipoprotein levels from 1960 to 2002 and 1990 to 2000, respectively.
Atrial Fibrillation and Dementia
Two independent meta-analyses published between 2011 and 2012 demonstrate that AF is associated with an increased risk of dementia. 41, 42 Estimates of the increased risk attributable to AF ranged from 42% to 100% across the 2 studies. One of these meta-analyses suggested that the association with dementia was observed primarily in patients with poststroke. 42 Mechanisms linking AF to dementia, other than a history of overt stroke, may stem from ischemic brain injury caused by reduced cardiac output, covert strokes, and microthromboemboli. 41 
Trends in Atrial Fibrillation
The FHS reported an increase in the prevalence and incidence of AF between 1958 and 2007, perhaps as a consequence of enhanced survival. 43 The Rotterdam study reported no consistent change in AF incidence between 1990 and 2000.
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Education and Dementia
The declining incidence of dementia in the FHS was only observed in people with a high-school diploma. 3 Numerous studies have suggested a protective effect of education against dementia and clinical AD. 44, 45 The protective effect of education does not seem to be caused entirely by better vascular health or healthier lifestyles. 44, 46 With higher educational attainment may come greater cognitive reserve, protecting against or delaying the clinical manifestations of dementia. 46 
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Trends in Education
Educational attainment has been increasing steadily in the United States. Only 25% of adults aged >24 years had completed a high-school diploma or higher in the year 1940. 47 This percentage rose to 50% in 1967, 75% in 1986, and 88% in 2015. Similarly, the percentage of people holding a bachelor's degree grew from 5% in 1940 to 33% in 2015.
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Diabetes Mellitus, Obesity, and Dementia
Our own research had found that, although diabetes mellitus was not associated with an increase in the risk of AD overall, patients with diabetes mellitus who were without other major risk factors for AD were almost 3× as likely to develop AD dementia. 48 A large meta-analysis of 14 studies reported that patients with type 2 diabetes mellitus were at a 60% increased risk of developing dementia. 49 Diabetes mellitus may increase dementia risk by causing cerebrovascular disease rather than AD pathology; a study of ≈2400 autopsies demonstrated that diabetes mellitus was associated with brain infarction but not with AD-type pathology. 50 Some contradictory findings have been reported on obesity and the risk of dementia. The association seems to be age dependent and nonlinear. One meta-analysis of prospective cohort studies found a U-shaped association between body mass index and dementia risk, with obesity predicting an 80% increase in the risk of incident AD dementia. 51 With respect to the influence of age, midlife obesity has been associated with an increased risk of later-life dementia, 51, 52 whereas later-life obesity has been associated with a reduced risk of dementia. 52 The relationship between midlife obesity and dementia may be underpinned by higher vascular risk and the influence of adipokines such as leptin. 53 Later-life obesity may indicate a reduced risk of AD given that weight loss may signify poor health, frailty, and the beginning of a neurodegenerative process. Thus, midlife obesity and diabetes mellitus have been associated with increased dementia risk whereas a decline in body mass index may precede incident dementia.
Diabetes Mellitus and Obesity: Bucking the Trend
Unlike many of the aforementioned vascular risk factors, rates of obesity and diabetes mellitus are increasing in the FHS and the United States. 3, 54, 55 It is unclear how rising rates of diabetes mellitus and obesity will influence future trends in dementia. Jones and Green 56 warn against complacency, noting that, as the burden of dementia is malleable, it can easily relapse.
Other Vascular Risk Factors
There are many other vascular risk factors, not discussed here, that are associated with dementia (ie, homocysteine, diet, and lifestyle). For example, the FHS demonstrated that elevated homocysteine was associated with an increased risk of AD dementia 57 and that fortification of enriched grain products with folic acid in the 1990s was linked with increases in folate status and reductions in homocysteine concentrations. 58 
Do Temporal Trends in Vascular Risk Factors
Contribute to the Declining Incidence of Dementia?
We have observed tremendous improvements in BP and other stroke risk factors over the same period in which we have observed a declining incidence of dementia. Studies have used Population Attributable Risk (PAR) estimates in an attempt to quantify the contribution of vascular risk factors to the global burden of AD. Results suggest that approximately half of AD cases might be attributable to a set of 7 modifiable risk factors: smoking, physical inactivity, midlife hypertension, diabetes mellitus, low educational attainment, and depression. 59 However, after accounting for nonindependence between risk factors, the number of AD cases potentially attributable to modifiable risk factors reduced to one third. 59 Vascular risk factors often coexist, and it is unclear whether the presence of any one risk factor is sufficient to cause dementia on its own. Thus, it cannot be assumed that reducing a single vascular risk factor will meaningfully lower the global burden of dementia.
Insight From the FHS
The declining incidence of dementia in the FHS coincides with a decline in stroke incidence and vascular risk factors and better treatment of those vascular risk factors (Figure) . However, in our recent analysis, trends in vascular risk factors did not convincingly account for the temporal trends in dementia (Table 1) . 3 In our study, first, we included adjustments for baseline levels of individual vascular risk factors, an aggregate measure of vascular risk in the Framingham Stroke Risk Profile and disease events such as stroke. Second, we included adjustments for midlife (age, 50 years) vascular risk factors. We did this because data comparing the second and third generation of FHS participants who were studied at average ages of 62 and 42 years, respectively, suggest that the impact of vascular risk factors on an individual may be greater earlier in life. 60, 61 Thus, when comparing the brain age of a hypertensive people with normotensive people using an aggregate imaging measure, a difference of 2 years was noted at the age of 62 years, versus 7 years at the age of 42 years.
However, such adjustments also did not substantially explain the observed trends in dementia incidence. Third, we examined temporal trends in the effects of stroke, cardiovascular disease, and vascular risk factors on dementia incidence. We observed that there was a decrease in the risk of dementia associated with having a stroke. Thirty years ago, the 5-year relative risk of developing dementia was 9× higher in people who had a stroke than in people free of stroke. In the past decade, it was only 40% greater. This improvement in risk associated with a stroke is likely because of detection of milder strokes using magnetic resonance imaging diffusion-weighted imaging, more effective early treatment and later rehabilitation, as well as better prevention of recurrent strokes. The risk of dementia associated with heart failure and atrial fibrillation was also less in the third epoch relative to the first. 3 However, the lower risk associated with clinical stroke and other clinical cardiovascular events only partly explained the favorable trends in dementia risk in the FHS sample. In summary, improvements in vascular health did not completely account for the declining incidence of dementia in our analyses.
Challenges in Understanding the Role of Vascular Risk Factors in Dementia Risk
Should we conclude that the declining temporal trends in dementia are not because of improvements in vascular health? We urge caution in jumping to this conclusion because there are many sources of potential impact that need to be considered (Table 2) . 62, 63 Our research has linked numerous vascular risk factors to the risk of developing dementia later in life, including AD, and the complexities of these associations should not be underestimated. The relationship between any 1 vascular risk factor and dementia is dynamic and can change over the lifespan. Individuals seem to move through different time windows with aging, in each of which, different risk factors assume greater importance. Risk factors may even have different effects depending on age, as in the case of hypertension 18 and obesity. 52 In a recent issue of Stroke, we demonstrated that adhering to the American Heart Association's Ideal-Cardiovascular Health guidelines was associated with a reduced risk of incident VaD, but neither all-cause dementia nor AD dementia. 64 When we examined Ideal-Cardiovascular Health just 6 years earlier in life, higher scores predicted a reduced risk of incident all-cause dementia and clinical AD.
These and other examples demonstrate that noise, complexities in the data or failure to capture cumulated exposure may prevent us from understanding the true role of vascular risk factors in the declining incidence of dementia. Table 2 illustrates some of the challenges in understanding the role of vascular risk factors in the development of incident AD dementia. One important issue is that examining a vascular risk factor at a single time point does not provide information on cumulative exposure. This is a significant limitation because of the long preclinical phase and insidious nature of AD. Cumulated exposure to vascular risk factors could be investigated by using surrogate markers of exposure burden and indicators of preclinical disease. 65 As an example, left ventricular hypertrophy, carotid intima-media thickness, aortic atherosclerosis, white matter hyperintensity burden, or retinal pathology could be used as indicators of prolonged BP elevation over many years when compared with a BP measurement taken at a single time point. Another issue is the role of genetic variants in determining susceptibility to vascular risk and lifestyle changes. 62, 66, 67 
We Must Respond to the Evidence and Additionally Consider Nonvascular Factors
Whereas the appropriate prevention, treatment, and management of vascular disease are undeniably important for the prevention of stroke and vascular cognitive impairment, we must consider the role of nonvascular factors in the declining incidence of dementia. We may need to go one step 7. Give and take: Declining trends in some vascular risk factors (ie, blood pressure levels) may be offset by increasing trends in others (ie, diabetes mellitus).
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further, temporarily hang our white coats, and consider that the explanation for the declining incidence of dementia need not be medical. Changes in education, culture, occupational demands, nutrition, social support, and environmental factors are all possible contributing factors remaining to be confirmed or refuted. The answer may also lie in changes experienced in early life or even in utero.
Conclusions
How we explain the declining incidence of dementia will substantially impact prevention guidelines, therapeutic strategies, research investment, and ultimately our ability to further reduce dementia risk in our aging population. 56 There is substantial evidence linking vascular risk factors to the risk of incident dementia, including clinical AD. However, the favorable trends in vascular risk factors do not entirely explain the declining incidence of dementia. Despite PAR estimates suggesting that vascular risk factors contribute to a significant portion of AD burden, the degree to which reducing individual vascular risk factors will mitigate the risk of dementia remains unclear, hard to quantify, and likely dependent on numerous interacting factors. Careful observational studies in this area will need to extend across multiple, large cohorts and the entire life course from early to late adult life. They should combine large meta-analyses to identify societal and public health interventions most effective in reducing population burden of risk with a search for targeted approaches that may be necessary to go further beyond these low-hanging fruit. Targeted prevention approaches will likely require that we examine the precise characteristics of the vascular or lifestyle risk factor that is most strongly associated with risk and protection, understand the underlying biological pathways, and identify the people, defined by genetics, concomitant disease, or other factors, most likely to benefit from such interventions.
The final proof will rest with methodologically sound intervention studies examining how the treatment of vascular risk factors affects the risk of dementia and surrogate end points such as cognition and brain atrophy. However, such intervention studies completed to date have mostly yielded discouraging results. 21, 38 We must listen to the evidence and consider the complimentary role of nonvascular factors in the declining incidence of dementia. The favorable trends raise hope that morbidity because of dementia can be delayed and diminished and urge renewed investment in understanding, sustaining, and accelerating this trend.
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